Jaime L. B.
- Country
- Spain
- Department
- Alergologia
Research Overview
- Randomized crossover trial of QVM149 (indacaterol acetate/glycopyrronium bromide/mometasone furoate) versus salmeterol/fluticasone in 12‑17‑year‑olds with asthma
- Phase 3b/4 Randomized Double‑Blind Study of Depemokimab 100 mg SC Q26 weeks vs Placebo on Exacerbations and Lung‑Function Decline in Adults/Adolescents with Type 2 Asthma
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of Tezepelumab in Pediatric Patients Aged 5 to <12 Years with Severe Uncontrolled Asthma
Data & Insights
Has run more than one trial at 60 of 223 partner sites.
Specializations
Pediatric Respiratory Medicine
This investigator specializes in treating severe asthma conditions in children, with particular emphasis on age groups ranging from 5 to 12 years. Their research encompasses the evaluation of novel therapeutic approaches for young patients with uncontrolled asthma symptoms.
- Childhood Severe Uncontrolled Asthma
- Pediatric Eosinophilic Asthma
- Respiratory Function Assessment
Their work focuses on understanding respiratory dynamics in pediatric populations with challenging asthma presentations.
Inflammatory Airway Disease
The investigator concentrates on eosinophilic inflammation pathways in severe asthma, studying targeted therapeutic interventions for patients with elevated eosinophil levels. Their expertise extends to examining inflammatory markers in airways.
- Eosinophilic Phenotype Analysis
- Airway Inflammation Mechanisms
- Bronchial Response Patterns
Their research examines the relationship between inflammatory biomarkers and clinical outcomes in asthma patients.
Therapeutic Innovation
The investigator evaluates novel biological treatments for severe asthma, including assessment of various therapeutic agents like tezepelumab, benralizumab, and glycopyrronium bromide. Their work includes monitoring lung function improvements and exacerbation reduction.
- Biological Therapy Assessment
- Treatment Response Evaluation
- Long-term Efficacy Studies
Their research contributes to advancing treatment options for patients with severe asthma presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.